Portfolio

1 | 2 | 3 | 4

ActivBiotics

ActivBiotics is a biopharmaceutical company focused on the discovery, development and commercialization of therapies for the treatment of inflammatory diseases and bacterial infections. The firm, located in Lexington, MA, has a lead product candidate, rifalazil, in Phase III clinical trials for peripheral arterial disease (PAD).

AngioLink

» www.medtronic.com

Angiolink developed an innovative wound closure system for arterial punctures created during catheter insertion. The medical device company, founded in 1999 and located in Taunton, MA, was acquired by Medtronic in 2005.

Applied Spine

» www.appliedspine.com

Applied Spine Technologies is a New Haven, CT-based surgical implant company developing treatments for chronic lower back pain that are less invasive than fusion surgery. The company’s flagship product, Stabilimax NZ®, is currently in clinical trials.

BioValve, Inc.

» www.biovalve.com

BioValve Technologies, Inc., located in Parsippany, NJ, recently spun off Valeritas to develop its disposable miniaturized insulin pump for Type 2 diabetics which it expects to introduce into the market in 2008. The remainder of the company is focused on the development of new chemical entities that support the treatment of conditions of the central nervous system.

1 | 2 | 3 | 4

"As a CEO, I value both BioVentures Investors' experience in building shareholder value and their background as founders and advisors to emerging companies."

Peter Vitulli
President & CEO
Sciona

» Read Success Story

"BioVentures Investors brings a wealth of operating experience and scientific knowledge."

Stella M. Sung, Ph.D.
Chief Business Officer
Cylene Pharmaceuticals

» Read Success Story

"I'd call BioVentures Investors a 'user-friendly' venture capital firm. They understand technology development timelines and the issues related to medical devices."

Steven J. Tallarida
President Spirus Medical and ,
Founder AngioLink Corporation.

» Read Success Story

"What really sets them apart is their maturity, their understanding of the whole world of start-ups and what it takes to get a new idea and technology off the ground."

James Lousararian
President & CEO
Verax Biomedical

» Read Success Story